PolyPid Ltd. (PYPD)
5.02
+0.19
(+3.93%)
USD |
NASDAQ |
May 22, 16:00
5.04
+0.02
(+0.40%)
After-Hours: 20:00
PolyPid Shareholders Equity (Quarterly) : 8.78M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 8.228B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 43.63M |
| Purple Biotech Ltd. | 9.722M |
| Sol-Gel Technologies Ltd. | 22.81M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.16M |
| Total Liabilities (Quarterly) | 10.38M |
| Debt to Equity Ratio | 0.2669 |
| Current Ratio | 1.782 |
| Net Debt Paydown Yield | 1.73% |